Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 10
2003 16
2004 12
2005 18
2006 13
2007 13
2008 14
2009 9
2010 12
2011 20
2012 19
2013 21
2014 25
2015 23
2016 31
2017 35
2018 29
2019 33
2020 40
2021 51
2022 44
2023 48
2024 49
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

521 results

Results by year

Filters applied: . Clear all
Page 1
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium.
Han JX, Koh MJ, Boussi L, Sorial M, McCabe SM, Peng L, Singh S, Eche-Ugwu IJ, Gabler J, Fernandez Turizo MJ, MacVicar CT, Garg A, Disciullo A, Chopra K, Lenart A, Nwodo E, Barnes J, Koh MJ, Miranda E, Chiattone C, Stuver R, Horwitz SM, Merrill M, Jacobsen E, Manni M, Civallero M, Skrypets T, Lymboussaki A, Federico M, Kim Y, Kim JS, Cho JY, Eipe T, Shet T, Sridhar E, Shetty A, Saha S, Jain H, Sengar M, Van Der Weyden C, Prince HM, Hamouche R, Murdashvili T, Foss F, Gentilini M, Casadei B, Zinzani PL, Okatani T, Yoshida N, Yoon SE, Kim WS, Panchoo G, Mohamed Z, Verburgh E, Alturas JC, Al-Mansour M, Ford J, Cabrera ME, Ku A, Bhagat G, Ma H, Sawas A, Kariya KM, Iwasaki M, Bhanushali F, O'Connor OA, Marchi E, Shen C, Shah D, Jain S. Han JX, et al. Among authors: zinzani pl. Blood Adv. 2025 Feb 11;9(3):583-602. doi: 10.1182/bloodadvances.2024014674. Blood Adv. 2025. PMID: 39481087
Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet.
Ribrag V, Bron D, Rymkiewicz G, Hoelzer D, Jørgensen J, de Armas-Castellano A, Trujillo-Martín M, Fenaux P, Malcovati L, Bolaños N, Ribera JM, Herbaux C, Sarkozy C, Zinzani PL, Walewski J, Chamuleau MED. Ribrag V, et al. Among authors: zinzani pl. Lancet Haematol. 2025 Feb;12(2):e138-e150. doi: 10.1016/S2352-3026(24)00351-X. Lancet Haematol. 2025. PMID: 39909657 Review.
Correction: Bertuzzi et al. Microenvironmental Traits of Classical Hodgkin's Lymphoma in Adolescents and Their Prognostic Impact. Cancers 2024, 16, 4210.
Bertuzzi C, Righi S, Motta G, Rossi M, Carella M, Gabrielli G, Facchini E, Baldassarre M, Prete A, Zinzani PL, Mascolo M, Agostinelli C, Sabattini E. Bertuzzi C, et al. Among authors: zinzani pl. Cancers (Basel). 2025 Jan 27;17(3):429. doi: 10.3390/cancers17030429. Cancers (Basel). 2025. PMID: 39913172
The A-HIPI Prediction Model in Advanced Stage Hodgkin Lymphoma: Identification of Risk Groups and Creation of an Online Tool.
Maurer MJ, Parsons SK, Upshaw JN, Rodday AM, Mwangi R, Rossetti S, Friedberg JW, Gallamini A, Federico M, Hawkes EA, Hodgson D, Johnson PWM, Link BL, Mou E, Savage KJ, Zinzani PL, Evens AM. Maurer MJ, et al. Among authors: zinzani pl. Blood Adv. 2025 Jan 8:bloodadvances.2024014689. doi: 10.1182/bloodadvances.2024014689. Online ahead of print. Blood Adv. 2025. PMID: 39778124 No abstract available.
A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell Lymphomas.
Kim WS, Shortt J, Zinzani PL, Mikhailova N, Radeski D, Ribrag V, Domingo Domenech E, Sawas A, Alexis K, Emig M, Elbadri R, Hajela P, Ravenstijn P, Pinto S, Garcia L, Overesch A, Pietzko K, Horwitz S. Kim WS, et al. Among authors: zinzani pl. Clin Cancer Res. 2025 Jan 6;31(1):65-73. doi: 10.1158/1078-0432.CCR-24-1913. Clin Cancer Res. 2025. PMID: 39531538 Free PMC article. Clinical Trial.
Linfoma diffuso a grandi cellule in terza linea (e oltre).
Broccoli A, Zinzani PL. Broccoli A, et al. Among authors: zinzani pl. Recenti Prog Med. 2025 Jan;116(1):1e-3e. doi: 10.1701/4416.44124. Recenti Prog Med. 2025. PMID: 39840878 Italian. No abstract available.
Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial.
Sureda A, Pinto A, Ghesquières H, Morschhauser F, Tournilhac O, Mutsaers P, Zijlstra JM, De Filippi R, Hilgier K, Manamley N, Janik T, Zinzani PL. Sureda A, et al. Among authors: zinzani pl. Hematol Oncol. 2025 Jan;43(1):e70000. doi: 10.1002/hon.70000. Hematol Oncol. 2025. PMID: 39617826 Free PMC article. Clinical Trial.
521 results